Danish Pharmacovigilance Update, September 2014

The September issue of Danish Pharmacovigilance Update.

News from the EU

• Denosumab (Prolia and Xgeva) and risk of osteonecrosis of the jaw and hypocalcaemia, page 2
• Interferon beta and risk of serious adverse reactions, page 4

News from the DHMA

• Scopoderm® transdermal patches and visual disturbances, page 5
• Childhood vaccinations and reported suspected adverse reactions in Q2 of 2014, page 6

Short news

• Most recent Direct Healthcare Professional Communications (DHPCs), page 13